Phase II trial of carboplatin (C) and bevacizumab (BEV) in patients (pts) with breast cancer brain metastases (BCBM).

被引：1
|
作者：
Lin, Nancy U.
Gelman, Rebecca Sue
Younger, W. Jerry
Sohl, Jessica
Freedman, Rachel A.
Sorensen, A. Gregory
Bullitt, Elizabeth
Harris, Gordon J.
Morganstern, Daniel
Schneider, Bryan P.
Krop, Ian E.
Winer, Eric P.
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Massachusetts Gen Hosp, Boston, MA 02114 USA
[3] Siemens Healthcare North Amer, Malvern, PA USA
[4] Univ N Carolina, Chapel Hill, NC USA
[5] Indiana Univ, Melvin & Bren Simon Canc Ctr, Indianapolis, IN 46204 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
513
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Randomized phase II study comparing pathological responses of resected colorectal cancer metastases (CRCM) after bevacizumab (BEV) with FOLFOX or FOLFIRI (BEV-ONCO trial)
    Baldin, P.
    Beniuga, G.
    Jouret-Mourin, A.
    Demolin, G.
    Roland, S.
    D'Hondt, L. A.
    Vergauwe, P.
    Vandaele, D.
    Mailleux, M.
    Sinapi, I.
    De Cuyper, A.
    Bletard, N.
    Massart, B.
    Delos, M.
    Castella, M-L.
    van Maanen, A.
    Carrasco, J.
    van den Eynde, M.
    ANNALS OF ONCOLOGY, 2020, 31 : S433 - S433
  • [32] Bevacizumab in the treatment of five patients with breast cancer and brain metastases: Japan Breast Cancer Research Network-07 trial
    Yamamoto, Daigo
    Iwase, Satoru
    Tsubota, Yu
    Sueoka, Noriko
    Yamamoto, Chizuko
    Kitamura, Kaoru
    Odagiri, Hiroki
    Nagumo, Yoshinori
    ONCOTARGETS AND THERAPY, 2012, 5 : 185 - 189
  • [33] Phase II trial of carboplatin, pemetrexed, and bevacizumab in metastatic nonsquamous (NSC) lung cancer
    Guarino, Michael J.
    Masters, Gregory A.
    Biggs, David
    Schneider, Charles
    Misleh, Jamal Ghazi
    Simpson, Pamela S.
    Suppiah, Kathiresan
    Wozniak, Timothy F.
    Grubbs, Stephen S.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [34] A phase II trial of temsirolimus (TEM) and bevacizumab (BEV) in patients with advanced hepatocellular carcinoma (HCC)
    Knox, Jennifer J.
    Qin, Rui
    Strosberg, Jonathan R.
    Kaubisch, Andreas
    El-Khoueiry, Anthony B.
    Bekaii-Saab, Tanios B.
    Erlichman, Charles
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [35] Phase II trial of irinotecan, carboplatin, and bevacizumab in patients with limited-stage small cell lung cancer
    Zubkus, J. D.
    Spigel, D. R.
    Greco, F. A.
    Yardley, D. A.
    Burris, H. A., III
    Vazquez, E.
    Farley, C.
    Patton, J. F.
    Hart, L.
    Hainsworth, J. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [36] Phase II trial of irinotecan, carboplatin, and bevacizumab in patients with extensive-stage small cell lung cancer
    Spigel, D. R.
    Hainsworth, J. D.
    Yardley, D. A.
    Burris, H. A., III
    Farley, C.
    Zubkus, J.
    Meng, C.
    Murphy, P.
    Saez, R.
    Greco, F. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [37] Phase II trial of weekly docetaxel (DOC) and prolonged capecitabine (C) in metastatic breast cancer (MBC) patients (pts).
    Shapiro, CL
    Ramaswamy, B
    Rhoades, C
    Kendra, K
    Allen, J
    Hauger, M
    Loughlin, H
    Moore, T
    Villalona, M
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S203 - S203
  • [38] PROLONGED SURVIVAL AFTER BREAST CANCER BRAIN METASTASES (BCBM): WHO HAS A CHANCE?
    Tomasevic, Zorica
    Kovac, Zeljko
    Tomasevic, Zoran
    Milovanovic, Zorka
    BREAST, 2013, 22 : S46 - S47
  • [39] Phase II multicenter trial of a weekly paclitaxel and carboplatin regimen in patients with advanced breast cancer
    Loesch, D
    Robert, N
    Asmar, L
    Gregurich, MA
    O'Rourke, M
    Dakhil, S
    Cox, E
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (18) : 3857 - 3864
  • [40] PHASE-II TRIAL OF CARBOPLATIN AND ETOPOSIDE ACTIVITY IN PRETREATED BREAST-CANCER PATIENTS
    VINOLAS, N
    DANIELS, M
    ESTAPE, J
    GRAU, JJ
    PALOMBO, H
    SOLA, C
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1992, 15 (02): : 160 - 162
12345